These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Perspectives. CMS and Wall Street report... Med Health; 2003 Jan; 57(4):7-8. PubMed ID: 12602066 [No Abstract] [Full Text] [Related]
9. Prescription drug pushers. Patents and ads are the big reasons pills are priced like perfume and caviar. Sherrid P US News World Rep; 2000 Oct; 129(17):40-2. PubMed ID: 11184929 [No Abstract] [Full Text] [Related]
10. Drugmakers fight for good name. Stakes high, challenges many for providers who seek generic products. Becker C Mod Healthc; 2001 Aug; 31(35):28-33, 1. PubMed ID: 11550428 [TBL] [Abstract][Full Text] [Related]
11. Unsettling drug patent settlements: a framework for presumptive illegality. Carrier MA Mich Law Rev; 2009 Oct; 108(1):37-80. PubMed ID: 20535881 [TBL] [Abstract][Full Text] [Related]
12. The ongoing regulation of generic drugs. Frank RG N Engl J Med; 2007 Nov; 357(20):1993-6. PubMed ID: 18003956 [No Abstract] [Full Text] [Related]
13. Strategic options for brand-name prescription drugs when patents expire. Mehta SC; Mehta SS Health Mark Q; 1997; 14(3):107-14. PubMed ID: 10167309 [TBL] [Abstract][Full Text] [Related]
14. Patent watch. Harrison C Nat Rev Drug Discov; 2013 Jan; 12(1):14-5. PubMed ID: 23274462 [No Abstract] [Full Text] [Related]
17. Generics industry and doctors nervous over free trade deal. Burton B BMJ; 2004 May; 328(7449):1158. PubMed ID: 15142916 [No Abstract] [Full Text] [Related]
18. [Free trade agreements make the drugs more expensive]. Jeppsson A Lakartidningen; 2009 Nov 18-24; 106(47):3181. PubMed ID: 20082499 [No Abstract] [Full Text] [Related]